Literature DB >> 11341983

HCV core protein modulates Rb pathway through pRb down-regulation and E2F-1 up-regulation.

J Cho1, W Baek, S Yang, J Chang, Y C Sung, M Suh.   

Abstract

It has been recognized that the HCV (hepatitis C virus) core protein plays an important role in hepatocarcinogenesis. The functional inactivation of the Rb pathway appears to be a major event for multi-step cancer carcinogenesis. To elucidate the role of the HCV core protein in hepatocarcinogenesis, we investigated the effect of the HCV core protein on the Rb pathway in both Rat-1 cell lines, stably expressing the HCV core protein and the doxycycline-regulated cell lines. The HCV core stable transfectants showed a dramatic decrease in the pRb levels and E2F-1 up-regulation. In the doxycycline-regulated cell lines, the pRb levels were significantly decreased which are followed by E2F-1 up-regulation. HCV core stable transfectants showed higher cell growth rates and were sensitize to apoptosis. Thus, our results first indicate that the HCV core protein decreases the expression of pRb, thereby allowing E2F-1 to be constitutively active, which is thought to result in rapid cell proliferation or sensitizing to apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11341983     DOI: 10.1016/s0167-4889(00)00137-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

1.  Rb/E2F1 regulates the innate immune receptor Toll-like receptor 3 in epithelial cells.

Authors:  Manabu Taura; Mary Ann Suico; Kosuke Koyama; Kensei Komatsu; Rui Miyakita; Chizuru Matsumoto; Eriko Kudo; Ryusho Kariya; Hiroki Goto; Shunsuke Kitajima; Chiaki Takahashi; Tsuyoshi Shuto; Mitsuyoshi Nakao; Seiji Okada; Hirofumi Kai
Journal:  Mol Cell Biol       Date:  2012-02-06       Impact factor: 4.272

Review 2.  Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.

Authors:  Michael J Bouchard; Sonia Navas-Martin
Journal:  Cancer Lett       Date:  2010-12-18       Impact factor: 8.679

3.  Down-regulation of PTEN by HCV core protein through activating nuclear factor-κB.

Authors:  Yong Zhang; Rong-Qing Li; Xu-Dong Feng; Yan-Hua Zhang; Li Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 4.  Viral hepatocarcinogenesis.

Authors:  W-L Tsai; R T Chung
Journal:  Oncogene       Date:  2010-03-15       Impact factor: 9.867

Review 5.  Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.

Authors:  Abhik Saha; Rajeev Kaul; Masanao Murakami; Erle S Robertson
Journal:  Cancer Biol Ther       Date:  2010-11-15       Impact factor: 4.742

6.  Computational identification of bioactive compounds from Cydonia oblonga Mill. against hepatocellular carcinoma by targeting pTEN and HBx-interacting protein.

Authors:  Elhan Khan; Iffat Zareen Ahmad
Journal:  J Mol Model       Date:  2022-06-17       Impact factor: 1.810

Review 7.  Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer.

Authors:  David R McGivern; Stanley M Lemon
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

8.  Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies.

Authors:  Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader; Mohamed Hassan
Journal:  World J Hepatol       Date:  2012-12-27

9.  Hepatitis C virus core proteins derived from different quasispecies of genotype 1b inhibit the growth of Chang liver cells.

Authors:  Xue-Bing Yan; Lei Mei; Xia Feng; Mei-Rong Wan; Zhi Chen; Nicole Pavio; Christian Brechot
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

10.  Hepatitis C virus causes uncoupling of mitotic checkpoint and chromosomal polyploidy through the Rb pathway.

Authors:  Keigo Machida; Jian-Chang Liu; George McNamara; Alexandra Levine; Lewei Duan; Michael M C Lai
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.